Česká společnost intenzivní medicíny (ČSIM) jako partnerská organizace Evropské společnosti intenzivní medicíny (ESICM)

Balík M.

Anest. intenziv. Med. 2025;36(1):3 | DOI: 10.36290/aim.2025.005

ČSARIM v roce 2025 – kde se nacházíme v polovině mandátu výboru?

Černý V.

Anest. intenziv. Med. 2025;36(1):4-5 | DOI: 10.36290/aim.2025.008

Ultrasound assessment of diaphragmatic movement post selective superior trunk block versus conventional interscalene block in shoulder arthroscopy

Sultan W. A., Metwally A. A., Soliman A. M., Mahdy W., Afify N.

Anest. intenziv. Med. 2025;36(1):8-14 | DOI: 10.36290/aim.2025.012

Study objective: Our aim was to evaluate the incidence of hemidiaphragmatic paralysis after selective superior trunk block compared to conventional interscalene block. Study design: A prospective double­‑blinded randomized controlled trial. Setting: University Hospital of Faculty of Medicine. Material and Method: Sixty­‑eight patients who were scheduled for shoulder arthroscopy were divided into two equal groups. The interscalene group received ultrasound­‑guided interscalene block and the superior trunk group received ultrasound­‑guided selective superior trunk block. A total volume of 15 ml of 0.25% bupivacaine was injected...

Post­‑sepsis syndrome

Fischer J., Hortová­‑Kohoutková M., Frič J., Šrámek V., Helán M.

Anest. intenziv. Med. 2025;36(1):15-21 | DOI: 10.36290/aim.2024.064

Sepsis as a life-threatening organ dysfunction caused by a deregulated immune response to infection remains one of the greatest human health-related concerns globally and even though huge advances in diagnostics and treatment of sepsis have been made, around 11 million sepsis-related deaths are reported every year worldwide. Only half of the sepsis survivors can achieve complete recovery 2 years after discharge, one-third die, and the remaining one-sixth suffer from long-term complications known as post-sepsis syndrome. It involves physical symptoms - fatigue, muscle weakness, dysphagia, and chronic pain; neuropsychiatric consequences - anxiety, depression,...

Alveolar-arterial oxygen difference in intensive care

Kutěj M., Haiduk F., Sagan J., Máca J.

Anest. intenziv. Med. 2025;36(1):22-28 | DOI: 10.36290/aim.2025.006

The alveolo-arterial oxygen difference (P_(A-a)O₂) describes the difference between alveolar and arterial oxygen tension. The primary purpose of P_(A-a)O₂ is to distinguish between extra- and intra-pulmonary causes of hypoxemia. P_(A-a)O₂ has come to the forefront again in the context of the SARS-CoV-2 (COVID-19) coronavirus pandemic, where relatively simple methods of patient triage and therapeutic approaches have been sought. In the intensive care setting, where it is almost always obvious whether the cause of hypoxemia is extrapulmonary or intrapulmonary, the importance of P_(A-a)O₂...

Fatal ecstasy (MDMA) intoxication with extreme hyperpyrexia, rhabdomyolysis, and disseminated intravascular coagulopathy

Mynář M., Samek J., Břízová P., Zátopková L., Hejna P., Turek Z.

Anest. intenziv. Med. 2025;36(1):29-33 | DOI: 10.36290/aim.2024.065

Ecstasy (MDMA - 3,4-methylenedioxymethamphetamine) is a synthetic psychoactive amphetamine with stimulatory effects on the user's sympathetic nervous system. The prevalence of MDMA misuse has been widely increasing in young people below 20 years of age. For first-time users, MDMA is considered the most dangerous drug in terms of serious complications such as extreme hyperpyrexia, rhabdomyolysis, disseminated intravascular coagulopathy, and brain edema. The presented case study describes fatal MDMA intoxication in young men with rapid onset of extreme hyperpyrexia above 42 °C, massive rhabdomyolysis, DIC, and multiple organ failure leading to death....

Our experience with VV ECMO­‑assisted surgery: case report series

Chovanec Z., Pestal A., Berkova A., Cervenak V., Penka I., Cundrle I.

Anest. intenziv. Med. 2025;36(1):34-38 | DOI: 10.36290/aim.2025.001

Veno­‑venous extracorporeal membrane oxygenation (VV ECMO) is a technique of extracorporeal support that facilitates blood gas exchange, enabling the complete replacement of lung function for a specified duration, such as during surgery. By using this method, we are able to provide surgical treatment to highly selected patients who would otherwise be unable to undergo thoracic surgery, including tracheal/carinal surgery and high­‑risk one­‑lung ventilation due to previous lung resection or severe lung impairment. This case series presents our experience with elective and acute ECMO­‑assisted thoracic surgery (excluding lung...

Nursing Care of a Central Venous Catheter

Kletečka J., Vlasáková A., Nosková P., Astapenko D.

Anest. intenziv. Med. 2025;36(1):39-42 | DOI: 10.36290/aim.2025.007

Nursing care for central venous catheters has undergone significant advancements in recent years due to new materials that reduce infection risk, enhance patient comfort, and allow for less frequent dressing changes. A key innovation is the use of sutureless fixation systems, which eliminate skin trauma caused by sutures while maintaining sufficient catheter stability. Other advanced methods, including transparent dressings, chlorhexidine-releasing dressings, and cyanoacrylate glue for exit site closure, help reduce bacterial colonization and infection risk. This review article focuses on the various materials used and the correct procedures for initial...

Iliocostalis plane block (ICPB): technical report

Nalos D., Beňo L., Škvára D.

Anest. intenziv. Med. 2025;36(1):43-45 | DOI: 10.36290/aim.2025.002

The article describes a variant of the erector spinae plane block (ESPB) on the chest. The application site is between the fascia of the iliocostalis muscle and the serratus posterior superior muscle. The distribution of the local anesthetic is medial to the distribution of the anesthetic in the case of erector spinae plane block (ESPB). The lateral direction is evidence of the spread of applied LA up to the mid-axillary line. The extent of analgesia is similar to that of ESPB. The application site is well identifiable and lies more superficially and far from the backbone structures than the ESPB application site. The block will look for indications...

Angiotensin II - mechanism of action, current evidence and position paper of the interdisciplinary working group on its use in intensive care settings

Balík M., Beneš J., Černý V., Kula R., Matějovič M., Říha H., Tencer T.

Anest. intenziv. Med. 2025;36(1):46-51 | DOI: 10.36290/aim.2025.004

The medicinal product Giapreza containing angiotensin II for intravenous administration has been registered in the Czech Republic since 2023. The article describes the mechanism of action of the drug, summarizes the current scientific evidence of its efficacy and safety, and presents the opinion of an interdisciplinary working group on the use of angiotensin II in intensive care units, especially in patients with refractory vasoplegic shock. The text has been endorsed by the Czech Society of Intensive Medicine, the Czech Society of Anesthesiology and Intensive Medicine, and the Czech Acute Cardiac Care Association.

Premedication in children: what if it fails?

Frelich M., Stašová B., Fišerová D., Astapenko D., Jor O.

Anest. intenziv. Med. 2025;36(1):52-54 | DOI: 10.36290/aim.2025.003

Zajímavosti z literatury

Horáček M., Málek J., Klučka J.

Anest. intenziv. Med. 2025;36(1):55-61 | DOI: 10.36290/aim.2025.010